Coya taps familiar friend Dr. Reddy’s to commercialize ALS med

Coya taps familiar friend Dr. Reddy’s to commercialize ALS med

Source: 
Fierce Biotech
snippet: 

Neurodegenerative biotech Coya Therapeutics has handed over key commercialization rights to an amyotrophic lateral sclerosis prospect to existing partner Dr. Reddy’s, and it's also fundraising off the deal.